LCN2 and chronic kidney disease: Second, NGAL may not serve as a reliable biomarker in patients with CKD, since its measurement accuracy could be interfered with various factors including the presence of urinary protein, age, eGFR, etc (Wagener et al., 2008; Sahu et al., 2022).